CDKN2B-AS1 and melanoma: In summary, our present study demonstrated that MTAP-ANRIL gene fusion can downregulate the expression of the wild-type tumor suppressor MTAP and promote melanoma cell migration via EMT-like process through the activation of JNK and p38 MAPKs.